The third robust NAFLD susceptibility gene, GCKR (encoding liver-specific glucokinase regulatory protein [GKRP]), is involved in de novo lipogenesis (Fig. 3a) [51], one of the principal pathways in the development of NAFLD [2]. The gene discussed is GCKR; the disease is metabolic dysfunction-associated steatotic liver disease.